Preclinical Toxicity and Pharmacokinetic Evaluation of Paclitaxel Nanodispersion.

Khopade AJ, Shah MD, Borole BS, Patel B, Pateliya B, Burade V

Open source

DOI
10.1208/s12249-025-03268-4
Published
2025 Dec 18
Container
AAPS PharmSciTech
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12249-025-03268-4,
  title = {Preclinical Toxicity and Pharmacokinetic Evaluation of Paclitaxel Nanodispersion.},
  author = {Khopade AJ and Shah MD and Borole BS and Patel B and Pateliya B and Burade V},
  year = {2025},
  journal = {AAPS PharmSciTech},
  doi = {10.1208/s12249-025-03268-4},
  url = {https://doi.org/10.1208/s12249-025-03268-4}
}

RIS

TY  - JOUR
TI  - Preclinical Toxicity and Pharmacokinetic Evaluation of Paclitaxel Nanodispersion.
AU  - Khopade AJ
AU  - Shah MD
AU  - Borole BS
AU  - Patel B
AU  - Pateliya B
AU  - Burade V
PY  - 2025
JO  - AAPS PharmSciTech
DO  - 10.1208/s12249-025-03268-4
UR  - https://doi.org/10.1208/s12249-025-03268-4
ER  - 

APA

AJ, K., MD, S., BS, B., B, P., B, P., & V, B. (2025). Preclinical Toxicity and Pharmacokinetic Evaluation of Paclitaxel Nanodispersion.. AAPS PharmSciTech. https://doi.org/10.1208/s12249-025-03268-4

Source records